SpaceX rocket to launch South Korea’s first military satellite

By Nikita Chaurasia  Date: 2020-07-13

SpaceX rocket to launch South Korea’s first military satellite

The SpaceX rocket which kick started company’s astronaut mission last month has reportedly once again fired its engines in a bid to set the stage for launching first Korean military satellite this week.

If reports are to be believed, the launch of Anasis-II communications satellite for military is planned on Tuesday (14th July) at 5 p.m. EDT (17:00 GMT).

Speaking of the move, SpaceX tweeted that the static fire test is completed, Falcon 9 launch of the ANASIS-II is planned on 14th July from SLC-40 located in Florida. They further added that NASA astronauts Doug Hurley and Bob Behnken were launched by Falcon 9 to International Space Station on SpaceX’s first crewed spaceflight Demo-2, on 30 May.

The rocket test happened as planned SpaceX launch of a distinct Falcon 9 rocket which carried two BlackSky Global Earth-imaging and 57 Starlink internet satellites from its nearby launch site Pad 39A at NASA Space Center, Kennedy. The test was called off by SpaceX on Saturday morning due to the necessity for more rocket checks.

As per Airbus, Anasis-II, fabricated by Airbus Defence and Space, is Korea’s first-ever military satellite designed with the intention to offer secured communications over a broad area. The satellite is built based on Eurostar E3000 satellite platform of Airbus and will be introduced into a geostationary orbit. These orbits enable satellites to retain its position over the Earth at an elevation of 22,000 miles (36,000 kms).

Spaceflight Now cites that Anasis-II was originally known as KMilSatCom. South Korea depended on international and civilian-owned satellites for communications needs, before this mission.

Source- https://www.space.com/spacex-test-fires-rocket-for-korean-military-satellite-anasis-2.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...